Our current research focuses on the sensitivity of two blood inflammatory markers (C-reactive protein [CRP] and procalcitonin [PCT]), measured in point-of-care testing (POCT) to support diagnosing UTI [17]. This evidence concerns the gene CRP and bacterial urinary tract infection.